Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.
Also called NCT01738100
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 100 participants
- Sponsor
- Hyeon-Cheol Gwon
- Registry
-
NCT01738100
-
- Other papers using this trial's data
- Cardioprotective Effects of Intracoronary Morphine in ST-Segment Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: A Prospective, Randomized Trial
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01738100. Randomized; no masking; primary purpose treatment. Start 2012-09 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Ticagrelor and Intracoronary Morphine in Patients Undergoing Primary Percutaneous Coronary Intervention
- Condition
- ST-Segment Elevation Myocardial Infarction
- Intervention (Drug)
- Ticagrelor
- Intervention (Drug)
- Clopidogrel
- Intervention (Drug)
- Morphine Sulfate
- Intervention (Drug)
- Saline
- Lead sponsor
- Hyeon-Cheol Gwon
Record details
- Record id
cardio:ct-nct01738100- Content hash
abe184ca43745e3d55c0358b2d1b133bb476b9c172bdb46fb95da0140de7c614